Vote Scores

Home / Companies / Aprea Therapeutics, Inc. / 5 Jun 2025

Meeting · year to 30 June 202524 filers reporting

Aprea Therapeutics, Inc.: meeting of 5 Jun 2025

Votes reported on Form N-PX, item by item

24 Form N-PX filers reported votes at the Aprea Therapeutics, Inc. meeting of 5 Jun 2025. Their records fall into 4 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

3 nominees; 74.1% of reported votes for; 2 filers withheld from or voted against at least one nominee.

27 vote records from 4 filers. 1 of the 4 filers that marked the item either way voted against management.

75.0% for0.0% against25.0% other25.0% against management4 filers
2

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

38 vote records from 23 filers. 1 of the 21 filers that marked the item either way voted against management. 2 filers reported this item without a management mark.

82.6% for0.0% against17.4% other4.8% against management23 filers64.0% for0.0% against36.0% other36.0% against management1,509,916 reported shares
3

SECTION 14A SAY-ON-PAY VOTESIssuer

Frequency of the say-on-pay vote

one year: 17 filers; three years: 2 filers; for: 1 filer; not applicable: 1 filer.

30 vote records from 22 filers. 2 of the 20 filers that marked the item either way voted against management. 2 filers reported this item without a management mark.

4.5% for0.0% against95.5% other10.0% against management22 filers31.8% for0.0% against68.2% other1.8% against management647,254 reported shares
4

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

9 vote records from 4 filers. 0 of the 4 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management4 filers100.0% for0.0% against0.0% against management174,392 reported shares

How the largest families voted

Family1. Directors2. Say-on-pay3. Pay-vote frequency4. Auditor
VanguardForForSplit or no voteFor
BlackRock and iSharesForForSplit or no voteFor
FidelityForForSplit or no voteFor
DimensionalAbstain or withhold *ForSplit or no vote *For
State Street and SPDRNo reportForSplit or no voteNo report
Goldman SachsNo reportSplit or no voteSplit or no voteNo report
Northern Trust and FlexSharesNo reportForSplit or no voteNo report
BNY MellonNo reportForSplit or no voteNo report

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the Aprea Therapeutics, Inc. meeting?

24 Form N-PX filers reported votes at the meeting of 5 Jun 2025. On say-on-pay, 1 of 21 voted against management (4.8%). The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Aprea Therapeutics, Inc. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Aprea Therapeutics, Inc.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Aprea Therapeutics, Inc. with a meeting date within three days of 5 Jun 2025. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.